CLINICAL_TRIALS
trial_result
· 2022-05-05
Clinical Trial Update: A Triple Combination Antiviral Coronavirus Therapy (TriACT) for COVID-19 [Phase 2]
Summary
Phase 2 trial update for TriACT, a triple combination antiviral therapy for COVID-19, terminated with posted results in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Rutgers, The State University of New Jersey | Conditions: SARS-CoV Infection, Covid19 | Phase 2 | Status: TERMINATED | Results posted: 2022-05-05